Nucleic Acid–Based Therapeutics in Orphan Neurological Disorders: Recent Developments

The possibility of rational design and the resulting faster and more cost-efficient development cycles of nucleic acid–based therapeutics (NBTs), such as antisense oligonucleotides, siRNAs, and gene therapy vectors, have fueled increased activity in developing therapies for orphan diseases. Despite...

Descripción completa

Detalles Bibliográficos
Autores principales: Khorkova, Olga, Hsiao, Jane, Wahlestedt, Claes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115123/
https://www.ncbi.nlm.nih.gov/pubmed/33996898
http://dx.doi.org/10.3389/fmolb.2021.643681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115123/
https://www.ncbi.nlm.nih.gov/pubmed/33996898
http://dx.doi.org/10.3389/fmolb.2021.643681

Ejemplares similares